Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Identification of a novel Rab11/25 binding domain present in Eferin and Rip proteins.

http://www.ncbi.nlm.nih.gov/pubmed/11481332

Rab11, a low molecular weight GTP-binding protein, has been shown to play a key role in a variety of cellular processes, including endosomal recycling, phagocytosis, and transport of secretory proteins from the trans-Golgi network. In this study we have described a novel Rab11 effector, EF-hands-containing Rab11-interacting protein (Eferin). In addition, we have identified a 20-amino acid domain that is present at the C terminus of Eferin and other Rab11/25-interacting proteins, such as Rip11 and nRip11. Using biochemical techniques we have demonstrated that this domain is necessary and sufficient for Rab11 binding in vitro and that it is required for localization of Rab11 effector proteins in vivo. The data suggest that various Rab effectors compete with each other for binding to Rab11/25 possibly accounting for the diversity of Rab11 functions.

Pubmed ID: 11481332 RIS Download

Mesh terms: Amino Acid Sequence | Animals | Carrier Proteins | Cell Line | Dogs | Dose-Response Relationship, Drug | Endosomes | Glutathione Transferase | Guanosine Triphosphate | Microscopy, Fluorescence | Molecular Sequence Data | Phagocytosis | Protein Binding | Protein Structure, Tertiary | Proteins | Receptor-Interacting Protein Serine-Threonine Kinases | Sequence Homology, Amino Acid | Two-Hybrid System Techniques | rab GTP-Binding Proteins | trans-Golgi Network

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.